06/08/2026
Clinicians don't resist AI. They resist ungoverned AI.
There's a difference, and most organizations are paying for it without knowing why.
I keep coming back to antimicrobial resistance as a frame for what's happening in healthcare AI right now. Antibiotics were one of the most important tools medicine ever produced. We overused them, deployed them without governance, and trained entire bacterial populations to stop responding.
The tool didn't fail. The deployment did.
AI in healthcare is walking the same road.
Every pilot that skipped clinical validation. Every rollout that skipped accountability. Every tool pushed onto a clinician's screen without a clear chain of responsibility behind it. Each one teaches the workforce something. And what it teaches them is to distrust the category, not just the product.
This is the part that gets underestimated.
→ Distrust doesn't reset when you buy a better tool.
→ It compounds across vendors, across departments, across years.
When a physician has been burned three times by AI outputs they couldn't verify, defend, or trace back to a source, the fourth tool walks into a room that's already closed. No training fixes that. No adoption campaign reverses it.
The lesson from AMR is simple. How you deploy a powerful tool matters as much as the tool itself. Governance isn't paperwork. It's what keeps the tool working long enough to matter.
If your AI strategy doesn't have clinical validation, accountability structures, and a way for clinicians to challenge outputs, you're not really deploying technology. You're funding future skepticism.
Curious what others in healthcare are seeing. Have you watched trust erode after a bad rollout, or has governance actually held the line?
Like & comment if you've felt this... on the floor or in the boardroom. 👇